Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The list of differential gene expression between BCSCs, qBCSC and activated qBCSCs

ABSTRACT: We report the whole transcriptome of BCSCs, qBCSCs, and activated qBCSCs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE123810 | GEO | 2019/10/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

The list of differential gene expression between BCSCs, qBCSC and activated qBCSCs

Project description:The list of differential gene expression between BCSCs, qBCSC and activated qBCSCs

| PRJNA509909 | ENA

The list of differential gene expression between BCSCsSETD4 and BCSCsGFP

Project description:We report the whole transcriptome of BCSCsSETD4 and BCSCsGFP

2019-10-25 | GSE123842 | GEO

Single-cell RNA sequencing of BCSCs from MCF7 cell lines

Project description:We report the single-cell transcriptome of breast cancer stem cells (BCSCs) from MCF7 cell lines.

2019-10-25 | GSE124887 | GEO

Single-cell RNA sequencing of BCSCs from solid tumors taken from NOD/SCID mice

Project description:We report the single-cell transcriptome of breast cancer stem cells (BCSCs) from solid tumors taken from NOD/SCID mice.

2019-10-25 | GSE124888 | GEO

All the regulated lncRNAs and mRNAs in BCSCs derived exosomes compared to non-BCSCs derived exosomes

Project description:Transcriptional landscapes between exosomes derived from BCSCs and non-BCSCs were compared using the LC Human ceRNA array V1.0 (4*180K, Design ID:085202) Microarray. Goal was to investigate potential lncRNAs involved in breast cancer progression through enveloping into exosomes.

2024-01-31 | GSE254074 | GEO

All the regulated lncRNAs in breast cancer stem cells (BCSCs, CD44+CD24- sorted)MCF-7 cells compared to non-BCSCs (non-CD44+CD24- sorted) MCF-7 cells

Project description:Circulating transcriptional landscapes between BCSCs and non-BCSCs were compared using the Affymetrix Human OE LncRNA Microarray with probes for profiling of 63542 human lncRNAs. Goal was to investigate potential lncRNAs involved in BCSCs progression.

2019-01-26 | GSE125678 | GEO

Single-cell RNA sequencing of BCSCs

Project description:Single-cell RNA sequencing of BCSCs

| PRJNA514086 | ENA

Single-cell RNA sequencing of BCSCs from MCF7 cell lines

Project description:Single-cell RNA sequencing of BCSCs from MCF7 cell lines

| PRJNA514090 | ENA

Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells

Project description:Background: Breast cancer stem cells (BCSCs) are considered responsible for cancer relapse and drug-resistance. Understanding the identity of BCSCs may open new avenues in breast cancer therapy. Although several discoveries have been made on BCSCs characterization, the factors critical to BCSCs is largely unclear. This study was aimed to determine whether genomic mutation contributes to the acquisition of cancer stem-like phenotype, and to investigate the genetic and transcriptional features of BCSCs. Methods: We detected the potential mutation hotspot regions by using whole genome sequencing on parental cancer cells and derived serial-generation spheroids in increasing order of BCSC frequency, and then performed target deep DNA sequencing in the level of bulk-cell and single-cell. To identify the transcriptional program associated with BCSCs, bulk-cell and single-cell RNA sequencing were performed. Results: By analyzing whole genome sequencing of bulk cells, potential BCSCs associated mutation hotspot regions were detected. Validation by target deep sequencing, in both bulk-cell and single-cell levels, revealed no genetic changes specifically associated with BCSC phenotype. Moreover, single-cell RNA sequencing showed that cancer cells display profound transcriptional variability at the single-cell level that predicts BCSC features. Notably, this transcriptomic variability is enriched in transcription of a number of genes, revealed as BCSC markers. Individuals with breast cancer in a high-risk recurrence group exhibited higher expression of these transcriptomic variabilities, highlighting their clinical significance. Conclusions: Transcriptional variability, not genetic mutations, distinguish BCSCs from non-BCSCs. The identified BCSCs markers can become novel targets for BCSCs.

2018-10-12 | GSE116180 | GEO

RNA-seq of wild-type and mfn2-/- activated muscle stem cells (mouse)

Project description:We report the transcriptome changes in purified mouse activated muscle stem cells in response to deletion of the Mfn2 gene.

2022-08-15 | GSE184376 | GEO